CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 61 filers reported holding CLEARSIDE BIOMEDICAL INC in Q1 2022. The put-call ratio across all filers is 2.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $10,467,000 | -58.5% | 3,806,018 | -9.5% | 0.15% | -59.8% |
| Q3 2021 | $25,241,000 | +23.2% | 4,206,765 | 0.0% | 0.38% | +23.3% |
| Q2 2021 | $20,487,000 | +97.2% | 4,206,765 | 0.0% | 0.31% | +90.7% |
| Q1 2021 | $10,391,000 | -4.2% | 4,206,765 | +6.3% | 0.16% | -11.0% |
| Q4 2020 | $10,845,000 | +78.4% | 3,958,130 | +0.3% | 0.18% | +24.7% |
| Q3 2020 | $6,079,000 | -17.5% | 3,947,518 | +0.8% | 0.15% | -29.5% |
| Q2 2020 | $7,365,000 | +11.6% | 3,917,622 | +0.9% | 0.21% | -27.1% |
| Q1 2020 | $6,602,000 | -39.3% | 3,883,490 | +3.6% | 0.28% | -30.7% |
| Q4 2019 | $10,875,000 | +360.6% | 3,750,107 | +0.1% | 0.41% | +192.9% |
| Q3 2019 | $2,361,000 | – | 3,747,699 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 2,462,500 | $11,993,000 | 6.16% |
| ACUTA CAPITAL PARTNERS, LLC | 1,316,268 | $6,410,000 | 2.56% |
| AJU IB Investment Co., Ltd. | 293,555 | $1,430,000 | 0.82% |
| RTW INVESTMENTS, LP | 4,206,765 | $20,487,000 | 0.31% |
| Carmignac Gestion | 3,419,877 | $16,655,000 | 0.19% |
| EAM Investors, LLC | 247,561 | $1,206,000 | 0.19% |
| Curi Wealth Management, LLC | 25,000 | $121,000 | 0.06% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 316,600 | $1,542,000 | 0.03% |
| TWO SIGMA ADVISERS, LP | 990,000 | $4,821,000 | 0.01% |
| CAXTON ASSOCIATES LP | 24,677 | $120,000 | 0.01% |